At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
SERPINA1 genegenetic
Likely dose
SERPINA1 gene 2mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of SERPINA1 Gene Polymorphisms in COPD as a Risk Factor for Periodontitis
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre·observational·Posted Jul 15, 2015·Updated Aug 29, 2016
In Brief
An observational study evaluating SERPINA1 gene for Pulmonary Disease, Chronic Obstructive and Generalized Chronic Periodontitis. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Chronic obstructive pulmonary disease and periodontitis are chronic inflammatory diseases. The study aims to determine if the genetic polymorphism of SERPINA1 gene in patients with COPD serve as a risk factor for developing periodontitis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedJul 2015
Primary CompletionNov 2015
Study CompletionDec 2015
TodayJul 2026
First PostedJul 15, 2015
Enrollment StartMar 1, 2015
Primary CompletionNov 1, 2015
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.0 years ago
Interventions
SERPINA1 genegenetic
2ml blood sample collected from patients to extract DNA for assessment of SERPINA1 gene polymorphism